Sunshine Biopharma (SBFM) Current Leases (2019 - 2026)
Sunshine Biopharma (SBFM) posted Current Leases of $209226.0 for Q1 2026, down 2.97% on a QoQ basis from $215637.0 in Q4 2025, and down 2.22% year-over-year from $213983.0 in Q1 2025.
Sunshine Biopharma (SBFM) Current Leases (2019 - 2026) Analysis & Trends
Sunshine Biopharma's Current Leases history runs 6 years deep, the most recent figure standing at $209226.0 for Q1 2026.
- Quarterly Current Leases fell 2.22% year-over-year to $209226.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $209226.0 (down 2.22% YoY) and the FY2025 annual result came in at $215637.0, up 3.79% from the prior year.
- Current Leases was $209226.0 for Q1 2026 at Sunshine Biopharma, down from $215637.0 in the prior quarter.
- Across five years, Current Leases topped out at $222496.0 in Q2 2025 and bottomed at $114452.0 in Q2 2024.
- A 5-year average of $159731.4 and a median of $122586.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases retreated 6.3% — and 2025, when it jumped 94.4%.
- Sunshine Biopharma's Current Leases stood at $123026.0 in 2022, then dropped by 3.54% to $118670.0 in 2023, then soared by 75.07% to $207756.0 in 2024, then rose by 3.79% to $215637.0 in 2025, then declined by 2.97% to $209226.0 in 2026.
- Business Quant data shows SBFM's Current Leases at $209226.0 in Q1 2026, $215637.0 in Q4 2025, and $218053.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 170,000.00 |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 209,226.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209,226.00 |
| Dec 31, 2025 | 215,637.00 |
| Sep 30, 2025 | 218,053.00 |
| Jun 30, 2025 | 222,496.00 |
| Mar 31, 2025 | 213,983.00 |
| Dec 31, 2024 | 207,756.00 |
| Sep 30, 2024 | 116,253.00 |
| Jun 30, 2024 | 114,452.00 |
| Mar 31, 2024 | 115,398.00 |
| Dec 31, 2023 | 118,670.00 |
| Sep 30, 2023 | 117,840.00 |
| Jun 30, 2023 | 122,146.00 |
| Mar 31, 2023 | 121,303.00 |
| Dec 31, 2022 | 123,026.00 |
| Mar 31, 2019 | 46,461.00 |